The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
The early-stage trial demonstrated an excellent safety profile alongside clinically meaningful improvements in visual acuity
Over 8.8?million Indians aged 60 and above currently live with dementia,
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
